Kent Thoelke is a Scientific Advisor of GI Partners. He is also currently the Chief Innovation Officer at ICON, having formerly held the Chief Scientific Officer role with PRA Health Sciences prior to its recent acquisition by ICON. With over 30 years in the drug development and clinical trials industry, Mr. Thoelke has had the opportunity to participate of drug research from the bench to the bedside globally. Having had the opportunity to work in biotech, pharma and the CRO industries, he brings a special perspective to the modernization of clinical trials.

*Senior Executive Advisors and Scientific Advisors (“Advisors”) are not employees of GI Partners. Advisors will provide certain services to GI Partners Funds and/or their portfolio companies.


  • B.A. Biology, Western Washington University